Back

Guideline-directed medical therapy titration for heart failure with ischaemic aetiology and its effect on cardiac remodelling and cardiovascular mortality-from a real world perspective

2 September 2024 (15:00 - 15:40)
Organised by: Logo
Congress Presentation Part of: Takotsubo cardiomyopathy and acute coronary syndromes Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jacopo Bonini

University of Ferrara, Ferrara (Italy)

5 More presentations in this session

Presentation thumbnail
Cardiac autonomic dysfunction in Takotsubo cardiomyopathy: an observational study
Doctor F. Hofer (Innsbruck, AT)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics and outcomes of patients with takotsubo syndrome and dynamic left ventricular outflow tract obstruction
Doctor D. Di Vece (Greifswald, DE)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of secondary prevention medical therapy in patients with Takotsubo cardiomyopathy: a Bayesian network meta-analysis
Doctor A. Zaka (Southport, AU)
Abstract Slides Video
Presentation thumbnail
A personalized, 3D printed, polymeric elastic support device for the prevention of post-MI cardiac remodeling
Doctor D. Nachman (Jerusalem, IL)
Abstract Slides Video
Presentation thumbnail
Utility of venoarterial extracorporeal membrane oxygenation in patients with acute myocardial infarction complicated by cardiogenic shock
Doctor S. Gupta (Stony Brook, US)
Abstract Slides Video

Access the full session

Session thumbnail
Takotsubo cardiomyopathy and acute coronary syndromes

The Event

Event poster

ESC Congress 2024

2 September 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Relationship between left ventricular reverse remodeling and guideline-directed medical therapy intensity in de novo heart failure with reduced ejection fraction patients: insight from TRANS-HF trial
thumbnail
Congress Presentation
Real-life management of heart failure: evaluation of medication optimisation in different phenotypes.
thumbnail
Congress Presentation
Initiation and titration of prognostic drug therapy during hospitalization for acute decompensation of heart failure with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources